Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression
A Pilot Study of Treatment for Refractory Depression With Sequential Trials of Tranylcypromine, Tranylcypromine Plus Dextroamphetamine, Tranylcypromine Plus Triiodothyronine.
Sponsor: New York State Psychiatric Institute
Terminated
Study is no longer funded.
Other terminated trials from New York State Psychiatric Institute
- Opioid Overdose · Phase PHASE2 · Oct 2024
- Cognitive Change · Phase NA · Jun 2024
- HIV Prevention · Phase NA · Apr 2023
- Cigarette Smoking · Phase NA · Dec 2022
- Chronic Pain · Phase NA · Aug 2022
See all terminations from New York State Psychiatric Institute
A PHASE4 clinical study on Major Depression, this trial is terminated or withdrawn. The trial is conducted by New York State Psychiatric Institute and has accumulated 6 data snapshots since 2001. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE4
First recorded
Sep 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- New York State Psychiatric Institute
For direct contact, visit the study record on ClinicalTrials.gov .